Bryan Hanson Made a Purchase of 25,077 Shares of Zimmer Biomet Holdings, Inc. (ZBH); Shorts at AGORA HOLDINGS (AGHI) Lowered By 97.3%

February 21, 2018 - By Danny Collins

In a public document filed with the U.S. Security and Exchange Commission, we discovered that the President and CEO of Zimmer Biomet Holdings Inc Bryan Hanson, an insider in spotlight, made a stock market deal for 25,077 shares of the public firm, valued at near $3.00 million US Dollars using an average stock price value of $119.7 US Dollars . The acquisition will most probably not stay unnoticed as it was big one. Now, he owns a total of 25,077 shares or 0.01% of the company’s market cap (share price times the number of shares outstanding).

AGORA HOLDINGS INC (OTCMKTS:AGHI) had a decrease of 97.3% in short interest. AGHI’s SI was 300 shares in February as released by FINRA. Its down 97.3% from 11,100 shares previously. The SI to AGORA HOLDINGS INC’s float is 0.01%. The stock decreased 0.57% or $0.002 during the last trading session, reaching $0.3478. About shares traded. Agora Holdings, Inc. (OTCMKTS:AGHI) has 0.00% since February 21, 2017 and is . It has underperformed by 16.70% the S&P500.

Agora Holdings, Inc., through its subsidiary, Geegle Media Inc., engages in the software development business in Canada. The company has market cap of $7.72 million. It specializes in developing Web, media, and lpTV applications, as well as operating support billing software for VOIP telephony. It currently has negative earnings.

Among 31 analysts covering Zimmer Biomet Holdings (NYSE:ZBH), 23 have Buy rating, 1 Sell and 7 Hold. Therefore 74% are positive. Zimmer Biomet Holdings has $158 highest and $92 lowest target. $134.29’s average target is 13.11% above currents $118.72 stock price. Zimmer Biomet Holdings had 91 analyst reports since August 27, 2015 according to SRatingsIntel. On Thursday, December 15 the stock rating was downgraded by UBS to “Sell”. The firm has “Buy” rating by Guggenheim given on Wednesday, July 12. The company was initiated on Thursday, March 17 by Nomura. The company was maintained on Thursday, December 21 by Jefferies. Morgan Stanley maintained the shares of ZBH in report on Thursday, November 2 with “Overweight” rating. The firm has “Hold” rating by Canaccord Genuity given on Monday, September 11. The firm has “Neutral” rating given on Friday, June 30 by Cantor Fitzgerald. RBC Capital Markets maintained Zimmer Biomet Holdings, Inc. (NYSE:ZBH) rating on Monday, November 6. RBC Capital Markets has “Buy” rating and $125.0 target. The rating was maintained by RBC Capital Markets on Wednesday, June 21 with “Outperform”. The firm has “Hold” rating by Canaccord Genuity given on Friday, July 28.

Since February 12, 2018, it had 0 insider purchases, and 1 sale for $2.41 million activity. Phipps Chad F sold $2.41M worth of stock.

Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, makes, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company has market cap of $24.04 billion. It operates through four divisions: Americas Spine, Office Based Technologies, Craniomaxillofacial and Thoracic , and Dental. It has a 13.15 P/E ratio. The firm provides orthopedic reconstructive products, such as knee and hip reconstructive products; S.E.T. products, including surgical, sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest.

Investors sentiment increased to 1.05 in Q3 2017. Its up 0.05, from 1 in 2017Q2. It increased, as 51 investors sold Zimmer Biomet Holdings, Inc. shares while 227 reduced holdings. 70 funds opened positions while 223 raised stakes. 170.76 million shares or 0.42% more from 170.05 million shares in 2017Q2 were reported. Aqr Cap Limited invested 0.02% of its portfolio in Zimmer Biomet Holdings, Inc. (NYSE:ZBH). 50,630 are held by Pillar Pacific Cap Mngmt Llc. Bokf Na reported 11,761 shares. 52,720 are owned by Schroder Investment Mgmt Group. Cohen Cap Mngmt Incorporated invested in 79,790 shares. Tocqueville Asset Limited Partnership accumulated 13,940 shares. Natl Pension Service holds 186,800 shares or 0.12% of its portfolio. Factory Mutual Ins Com reported 392,004 shares. Boyer & Corporon Wealth Limited Com holds 1.43% of its portfolio in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) for 29,158 shares. Commonwealth Equity has 33,552 shares. 190 are held by Plante Moran Advisors Limited Com. Quantitative Systematic Strategies Limited Liability Corp has invested 0.19% in Zimmer Biomet Holdings, Inc. (NYSE:ZBH). United Capital Fin Advisers invested 0.02% of its portfolio in Zimmer Biomet Holdings, Inc. (NYSE:ZBH). John G Ullman And Associates Inc holds 0.26% of its portfolio in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) for 11,274 shares. Tradewinds Cap Management Limited Liability Company holds 0.05% in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) or 862 shares.

The stock decreased 1.46% or $1.76 during the last trading session, reaching $118.72. About 663,733 shares traded. Zimmer Biomet Holdings, Inc. (NYSE:ZBH) has declined 0.44% since February 21, 2017 and is downtrending. It has underperformed by 17.14% the S&P500.